I suspect that many aspects of the ritual behaviour being investigated by anthropologist Harvey Whitehouse and his colleagues (Nature 493, 470-472; 2013) could well apply to academia, and to the scientific community in particular.
Science generally operates in what Whitehouse calls the 'doctrinal mode', but the 'imagistic mode' might also be relevant. Examples of the doctrinal mode include the ritual of the weekly lab meeting, the bonding induced by social outings, the ritualized nature of scientific conferences and the stereotypical behaviour of different lab members as they go about their research.
For the imagistic mode, what about the agony or ecstasy of having your paper rejected or accepted by Nature? Or the terrified first-year PhD student who has his or her results lambasted at a lab meeting or, worse, at a conference? It is not unknown for people to crumple under the onslaught of such a "traumatic ritual".
Studying the scientific community would be less dangerous than spending seven months in the middle of a civil war, and might encourage scientists to consider their own ritual behaviours. Denis R. Alexander The Faraday Institute for Science and Religion, Cambridge, UK. dra24@hermes.cam.ac.uk 
Educate physicians about investor types
As a venture capitalist at a US investment fund that supports young pharmaceutical companies, I believe that the misuse of clinical experts by a few hedge-fund investors should not prevent interaction with physicians (Nature 493, 271-272, 280-281; 2013) . Increasing regulation would risk stigmatizing physician participation in such expert networks, stifling information flow for investors and ultimately impeding drug discovery.
Academic and hospital conflict-of-interest policies that target or ban engagement with investment firms would need to differentiate between investor types. Hedge-fund investors operate in public markets and aim for a quick profit by betting on variables such as clinical-trial data, sales announcements or regulatory approval. Venture capitalists, by contrast, operate in private markets and aim for company growth over several years before selling to a large multinational or to investors through a public stock-market offering.
Unlike hedge-fund investors, venture capitalists holding public securities as insiders cannot profit by selling stock before the release of data. Furthermore, their interests are not threatened by confidential information leaks because of the longer-term nature of their investments.
It would be preferable for investors to identify conflicts of interest with respect to specific drugs before interviewing physicians, and to educate these experts formally on the potential pitfalls of engaging with investors. Justin Chakma Thomas, McNerney and Partners, La Jolla, California, USA. jchakma@tm-partners.com Inertia is speeding fish-stock declines A bluefin tuna weighing 222 kilograms sold for ¥155 million (US$1.7 million) in Tokyo last month. This is an alltime record price for a single fish, driven skywards by increasing demand and dwindling supply.
Populations of bluefin tuna (Thunnus spp.) are a fraction 
Fungus did not cause potato famine
The agent responsible for the blight that caused the nineteenth-century Irish potato famine, Phytophthora infestans, should not be "grouped with fungi" (Nature 493, 154-156; 2013) .
It was Anton de Bary, the father of mycology, who coined the genus name Phytophthora ('plant-destroyer') and classed the pathogen as a fungus. But modern molecular sequencing indicates that his interpretation was incorrect (M. D. M. Jones et al. Nature 474, 200-203; 2011 
